91Ë¿¹ÏÊÓÆµ

Lili Fu

Title: 
Associate Professor, Pathology
Contact Information
Address: 

91Ë¿¹ÏÊÓÆµ Health Center, Glen site
1001 boul. Décarie, Rm E04.4166
Montreal, QC H4A 3J1

Email address: 
lili.fu [at] mcgill.ca
Phone: 
(514) 934-1934 x43835
Degree(s): 

MDCM, MSc, MSc(A)

Area(s): 
Gynecological
Biography: 

Dr. Lili Fu obtained her MDCM degree from 91Ë¿¹ÏÊÓÆµ, following prior graduate training in Physiology. She completed her residency in Anatomical Pathology at the Department of Pathology at 91Ë¿¹ÏÊÓÆµ, and subsequently pursued fellowship training in gynecologic and breast pathology at the University of Toronto. She further enriched her experience through an observership in gynecologic pathology at Johns Hopkins Hospital. Dr. Fu joined the 91Ë¿¹ÏÊÓÆµ faculty in 2011 and has since developed a strong clinical and academic focus in gynecologic pathology. She is currently an Associate Professor of Pathology and a senior gynecologic pathologist at the 91Ë¿¹ÏÊÓÆµ Health Centre.

Current research: 

Dr. Lili Fu’s research work is based on collaboration with researchers and clinician-scientists at 91Ë¿¹ÏÊÓÆµ and the MUHC. Her research interest focuses on understanding the pathogenesis of gynecologic tumors and improving their diagnosis and classification through an integrated morphologic and molecular approach.

Dr. Fu’s current research activities include:

· Contribution to the DOVEE project at the MUHC, focused on identifying early diagnostic markers for ovarian cancer.

· Studies on the pathogenesis of ovarian cancer and its precursor lesions.

· A focus on rare gynecologic tumors, particularly those associated with hereditary cancer predisposition syndromes such as DICER1-related tumor predisposition. This was fostered by a research rotation in cancer genetics in 2018.

· Participation in the work of the Montreal-based international registry for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), and contribution in research on its mechanisms of chemotherapy resistance.

· Collaborative research on hereditary leiomyomatosis and renal cell carcinoma (HLRCC), aimed at improving recognition and characterization of FH pathogenic variants in Quebec and supporting earlier diagnosis.

Selected publications: 

Location: 
MUHC-Glen
Group: 
Associate Professors
Back to top